|
Re: Shares to Zenith
|
2
|
Resverlogix Corp.
|
Jan 03, 2019 09:18PM
|
|
Re: Why didn't management do some phase 2's,....
|
2
|
Resverlogix Corp.
|
Jun 19, 2019 09:35PM
|
|
Re: Annual Financial Reporting
|
2
|
Zenith Epigenetics
|
Mar 22, 2024 03:46PM
|
|
Re: General chances of success
|
2
|
Resverlogix Corp.
|
Feb 06, 2019 11:24AM
|
|
Re: What we know and what we don't.....
|
2
|
Resverlogix Corp.
|
May 16, 2019 05:17PM
|
|
Re: ACC/WCC Virtual 2020
|
2
|
Resverlogix Corp.
|
Mar 28, 2020 09:55AM
|
|
Re: Debt
|
2
|
Zenith Epigenetics
|
Apr 03, 2022 01:04PM
|
|
Re: Right of first refusal
|
2
|
Resverlogix Corp.
|
Mar 03, 2019 01:50PM
|
|
Re: Thoughts?
|
2
|
Resverlogix Corp.
|
Apr 06, 2021 09:51AM
|
|
Re: What we know and what we don't.....
|
2
|
Resverlogix Corp.
|
May 16, 2019 05:20PM
|
|
Re: Zenith-Oncology Pipeline
|
2
|
Zenith Epigenetics
|
Mar 19, 2021 06:49AM
|
|
Re: Hepa Links up close to the max 10% in early trading
|
2
|
Resverlogix Corp.
|
May 01, 2024 09:14AM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
2
|
Resverlogix Corp.
|
Dec 22, 2020 09:40AM
|
|
Re: Secured $6M Convertable Debenture
|
2
|
Resverlogix Corp.
|
Apr 16, 2024 02:40PM
|
|
Re: Why? How?
|
2
|
Resverlogix Corp.
|
Sep 20, 2024 06:23AM
|
|
Re: Talk about getting.....
|
2
|
Resverlogix Corp.
|
Jun 11, 2019 12:35PM
|
|
Re: Recent article; published in Clinical Epigenetics
|
2
|
Resverlogix Corp.
|
Jan 13, 2023 02:04PM
|
|
Re: maybe Zen will go first?
|
2
|
Resverlogix Corp.
|
May 04, 2020 01:39PM
|
|
Re: K2
|
2
|
Resverlogix Corp.
|
Apr 10, 2021 10:39AM
|
|
Re: If BP buys Apabetalone,...
|
2
|
Resverlogix Corp.
|
Nov 05, 2019 04:46PM
|
